Notification of Interim Results

RNS Number : 6933M

Immupharma PLC

20 September 2012

 



FOR IMMEDIATE RELEASE

20 September 2012

ImmuPharma PLC

Notification of Interim Results

Date: Wednesday 26 September 2012

ImmuPharma PLC (AIM:IMM), the specialist discovery and development pharmaceutical company, is scheduled to announce its Interim Results for the six months ended 30 June 2012 on Wednesday 26 September 2012.

For analysts who would like an update meeting with ImmuPharma's management team following the announcement of the results, please contact Lisa Baderoon, Head of Investor Relations, at the contact details given below.

Ends

For further information, please contact:

ImmuPharma plc	+ 44 (0) 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer	+ 44 (0) 20 7152 4080
Richard Warr, Chairman
Lisa Baderoon, Head of Investor Relations [e-mail]	+ 44 (0) 7721 413496
Buchanan	+ 44 (0) 20 7466 5000
Mark Court
Panmure, Gordon & Co., NOMAD & Broker	[phone]
Andrew Burnett
Fred Walsh
Espirito Santo Investment Bank, Joint Broker	[phone]
James Bromhead
Richard Crawley
Cenkos Securities plc, Joint Broker	[phone]
Stephen Keys, Camilla Hume (Corporate Finance)
Andy Roberts (Sales)

 

END

 

 

NORFKLLFLKFBBBL